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Abstract 
In this report, we describe the spontaneous malignant transformation of long-term cul-
tured human fetal striatum neural stem cells (hsNSCs, passage 17). After subcutaneous 
transplantation of long-term cultured hsNSCs into immunodeficient nude mice, 2 out of 
15 mice formed xenografts which expressed neuroendocrine tumor markers CgA and 
NSE. T1 cells, a cell line that we derived from one of the two subcutaneous xenografts, 
have undergone  continuous expansion in vitro. These T1 cells showed stem cell-like 
features and expressed neural stem cell markers nestin and CD133. The T1 cells were 
involved in abnormal karyotype, genomic instability and fast proliferation. Importantly, 
after long-term in vitro culture, the T1 cells did not result in subcutaneous xenografts, but 
induced intracranial tumor formation, indicating that they adjusted themselves to the 
intracranial microenvironment. We further found that the T1 cells exhibited an overex-
pressed level of EGFR, and the CD133 positive T1 cells showed a truncation mutation in 
the exons 2-7 of the EGFR (EGFRvIII) gene. These results suggest that continuous ex-
pansion of neural stem cells in culture may lead to malignant spontaneous transfor-
mation. This phenomenon may be functionally related to EGFR by EGFRvIII gene muta-
tion. 
Key words: tumorigenesis, malignant transformation, epidermal growth factor receptor (EGFR), 
xenograft 
Introduction 
Neural stem cells (NSCs) have the capability of 
self-renewal because at least one of the daughter cells 
maintains  neural  stem  cell  potential  by  asymmetric 
cell  division.  NSCs  differentiate  into  three  major 
neural cell types, neurons, oligodendrocytes and as-
trocytes  [1].  However,  the  proliferation  and 
self-renewal properties of NSCs may cause malignant 
transformation [2]. Although spontaneous malignant 
transformation was rarely observed, it has been sug-
gested that the spontaneous transformation of adult 
stem  cells,  such  as  human  mesenchymal  stem  cells 
(BM-hMSCs) and NSCs, can induce tumor formation 
[3-4].  The  spontaneous  transformation  of  murine 
neural precursor cells has been reported by Johnson 
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[5]  and  Florian  [6].  NSCs  have  been  considered  a 
promising  tool  for  cell  transplantation  therapy  and 
tissue engineering [7]. In order to obtain a sufficient 
amount  of  NSCs  for  clinical  use,  extensive  in  vitro 
expansion of NSCs is usually necessary. However, it 
remains a concern regarding the security of the NSCs. 
A  recent  report  revealed  that  the  fetal  neural  stem 
cells  transplanted  into  a  patient  with  a  hereditary 
neurodegenerative disease have grown into noncan-
cerous tumors in the brain and spinal cord [8]. Cancer 
stem  cells  have  recently  been  identified  as  can-
cer-initiating  cells  for  solid  malignancies  such  as 
breast  cancer  [10]  and  pediatric  brain  tumors  [11]. 
Thus, normal NSCs may be prone to genomic insta-
bility  and  malignant  transformation,  particularly 
during  long-term  culture  in  vitro.  Due  to  genomic 
instability,  accumulation  of  DNA  damage,  loss  of 
regulation in cell cycle, and deregulation of epigenetic 
signature may occur. 
To  investigate  whether  normal  NSCs  have  tu-
morigenic potential, we inoculated human fetal stri-
atum neural stem cells (hsNSCs) [12] subcutaneously 
into  immunodeficient  nude  mice.  We  observed  a 
spontaneous transformation of hsNSCs after 17 pas-
sages in vitro. Furthermore, a T1 tumor cell line that 
was derived from the hsNSCs following subcutane-
ous xenograft tumor formation was established and 
characterized.  We  found  that  the  tumorigenicity  of 
long-term cultured T1 cells showed strong selectivity 
in the microenvironment, which associated with the 
amplification  of  epidermal  growth  factor  receptor 
(EGFR) gene and a constitutively active mutant form 
of the receptor, EGFRvIII.  
 
MATERIALS AND METHODS 
Culture and enrichment of human fetal striatum 
neural stem cells  
The human fetal striatum neural stem cells were 
isolated  and  characterized  as  previously  described 
[12]. 
In vivo tumorigenicity assays  
All  animal  experiments  were  performed  in  ac-
cordance  with  the  guidelines  of  the  Animal  Care 
Committee, Peking University Health Science Center. 
Immunodeficient nude mice (4-5 weeks of age) were 
purchased  from  the  Experimental  Animal  Depart-
ment,  Peking University  Health Science Center. Ex-
perimental  group  with  15  mice  was  injected  with 
hsNSCs at passage 17 and was examined for tumor-
igenicity. Other 5 and 10 mice were used as positive 
control (injected with Hela cells) and negative control 
(injected with saline solution), respectively. 3×106 cells 
in 300 µl saline solution were subcutaneously injected 
into each mouse. The animals were monitored regu-
larly for tumor occurrence throughout the whole ex-
periment period.  
Isolation and culture of primary tumor cells from 
subcutaneous xenografts 
Immunodeficient nude mice with primary tumor 
formation  were  euthanized.  The  tumor  cells  were 
isolated, purified, and cultured in the primary culture 
medium of DMEM/F12 (Gibco, USA) supplemented 
with  10%  fetal  bovine  serum  (FBS,  Hyclone,  USA), 
EGF (20 ng/ml, PeproTech, USA), bFGF (20 ng/ml, 
PeproTech,  USA),  and  B27  (50x,  Invitrogen,  USA). 
When adherent clones reached about 95% confluence, 
they  were  transferred  to  a  new  flask  and  cultured 
continuously to form a monolayer. The populations of 
tumor cells were isolated from neoplasias after at least 
five passages. We named this cell population as T1 
cells.  
Serial subcutaneous xenografts 
The xenograft tissues were obtained through se-
rial subcutaneous passage in immunodeficient nude 
mice. Small non-necrotic xenograft tissues were me-
chanically  crumbled  and  passed  through  a  100-µm 
cell sieve (Falcon). Then 4-week-old immunodeficient 
nude mice were implanted subcutaneously with tiny 
tissue fragments of the xenografts. The animals were 
monitored regularly for tumor occurrence throughout 
the whole survival period. Five mice were inoculated 
for each experiment. The  tumor formation rate and 
the size of the neoplasias were recorded, and the ex-
periment was repeated.  
G-banding Chromosome Analysis  
Cell chromosome analysis was performed using 
the conventional Giemsa staining. Karyotypic analy-
sis  was  performed  using  an  Olympus  microscope 
(Optronic  cooled  CCD)  and  the  dedicated  cy-
toscan-karyotyping FISH & CGH system (United Bi-
otechnology USA corporation).  
DNA fingerprinting analysis using human short 
tandem repeat (STR) markers 
DNA  fingerprinting  analysis  was  performed 
using genomic DNA from NSCs (passage 9 and 17). 
The control cells and T1 cells were examined for hu-
man STR marker expression using the PowerPlex® 16 
System Kit (Promega Corp, Madison, WI) on an au-
tomated ABI 310 Genetic Analyzer (Applied Biosys-
tems, Foster City, CA). Int. J. Biol. Sci. 2011, 7 
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Measurement of cell proliferation  
For cell cycle analysis, DNA was labeled with 20 
μg/ml propidium iodine (Sigma, USA). The cell cycle 
was analyzed using FACScalibur flow cytometry with 
ModiFit  software.  For  the  PCNA  analysis,  nuclear 
antigen  was  stained  with  fluorescein  (Fluorescein 
isothiocyanate,  FITC)  labeled  with  anti-PCNA  anti-
body (Becton Dicksinson). Mouse FITC-IgG2a (Becton 
Dicksinson) was used as isotype control. Stained cells 
were  analyzed  using  FACScalibur  flow  cytometry 
(Becton  Dicksinson).  The  result  was  shown  as  the 
overlaid histograms of PCNA with its isotype control. 
Flow Cytometric Immunophenotypic Studies 
For membrane antigen staining, cells were tryp-
sinized into single cell suspension in a total volume of 
100µl PBS/BSA and immediately stained for 15min at 
room temperature in darkness with fluorescein (FITC) 
labeled  antibodies,  including  anti-CD133,  CD117, 
CXCR4 and EGFR. Mouse IgG2a-FITC or IgG1-FITC 
(Becton – Dickinson)  was  used  as  isotype  control. 
Stained cells were analyzed by FACScalibur flow cy-
tometry (Becton–Dickinson). 
Intracranial tumorigenic assays  
Ten  immunodeficient  nude  mice  were  divided 
equally  into  the  experimental  group  and  control 
group. 5×105 isolated tumor cells were intracranially 
injected into five immunodeficient nude mice. When 
symptom of hydrocephalus was observed, the intact 
brains were removed and paraffin embedded for H&E 
staining.  Normal  human  fetal  striatum  neural  stem 
cells were injected into the control mice. All surgical 
interventions and animal care were provided in ac-
cordance with the Guide for the Care and Use of Labor-
atory Animals of the National Institutes of Health.  
Immunofluorescence assays 
To  stain  the  cytoplasmic  and  nuclear  proteins, 
cells were incubated with relevant primary antibodies 
at 4℃ overnight and subsequently with appropriate 
secondary fluorescence-conjugated antibodies. Mouse 
or rabbit normal serum was used as a negative con-
trol.  The  primary  antibodies  included  a  mouse  an-
ti-human  antibody  specific  for  nuclei  (Chemicon, 
1:100), a mouse anti-human antibody specific for the 
epidermal growth factor receptor (Chemicon, 1:100), 
and  a  rabbit  anti-GFAP  polyclonal  antibody 
(Chemicon, 1:100). DAPI was used for nuclear stain-
ing. Fluorescence signals were detected using a Con-
focal  microscope  (Leica  TCS  SP5, German)  or  an 
Olympus  immuno-fluorescent  microscope  (Model 
BX51TR)  with  an  Apogee  Instruments  Microscopy 
Fluorescence System (Model KX85).  
Purification of CD133+ cells  
CD133+  cells  were  purified  by  magnetic  cell 
sorting  (MACS)  using  the  CD133  MicroBead  Kit 
(Miltenyi Biotech), and analyzed by the flow cytome-
try system using CD133/2-PE (Miltenyi Biotech). For 
reverse-transcriptase-PCR (RT-PCR) assay, total RNA 
was  extracted  from  the  sorted  CD133+  cells.  Com-
plementary DNA (cDNA) was synthesized. 5' (sense) 
primer  was:  5'-CTTCGGGGAGCAGCGATGCG 
AC-3',  3'  (antisense)  primer  was:  5'- 
ACCAATACCTATTCCGTTACAC-3'.  RT-PCR  prod-
ucts  yielded  two  fragments,  a  1044-bp  (wild-type) 
fragment and a 243-bp (deletion product) fragment. 
PCR products were subcloned into the pGEM-T easy 
cloning vector (Invitrogen) and sequenced. 
RESULTS 
Transformation of Long-term Cultured hsNSCs as 
Revealed in Subcutaneous Xenograft 
Among the 15 mice transplanted with cultured 
hsNSCs (passage 17), xenografts formed in two mice 3 
months after implantation (Fig. 1A, 1B), whereas tu-
mors formed in five of five mice transplanted  with 
Hela cells. No tumor was formed in the negative con-
trol mice injected with saline (data not shown). These 
results  suggested  a  risk  of  tumorigenesis  from  the 
transplantation  of  long-term  cultured  hsNSCs.  The 
H&E staining results showed that the neoplasias pro-
liferated actively and were of heterogeneity of nucleus 
(Fig. 1E,1F). The immunohistochemistry results indi-
cated that, pathologically, these tumors belonged to 
the  neuroblastoma-like  tissue  pattern  (Fig.  1G-1L). 
They were positive for CgA (Fig. 1G) and NSE (Fig. 
1H), but were negative for CD99 (Fig. 1I), cytokeratin 
AE1/AE3 (Fig. 1J), synaptophysin (Fig. 1K) and GFAP 
(Fig.  1L).  The  tumor  cells  form  the  hsNSC  injected 
mice was isolated, purified and cultured, we named 
them as T1 cells. The Karyotype analyses were per-
formed on passage 17 hsNSCs and the T1 cells. Met-
aphases were determined for each karyotype analysis, 
and the representative karyotype was shown in Fig 
1C and 1D. The chromosome dispersion of the T1 cells 
ranged from 60 to 70 chromosomes. A large number 
of  different  numerical  and  structural  chromosomal 
aberrations were detected in the T1 cells but not in the 
parent hsNSCs, which showed a normal complement 
of chromosomes and no genetic abnormality (Fig. 1C, 
1D).  
Establishment and characterization of the T1 
cell line  
T1 cells were isolated as described in the Mate-
rials and Methods. To evaluate  the proliferation ca-Int. J. Biol. Sci. 2011, 7 
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pacity of the T1 cells, the cell cycle was analyzed by 
flow cytometry. The percentages were 42.60% for the 
S phase cells (Fig. 2A), and  91.46% positive for the 
proliferation cell nuclear antigen (PCNA) (Fig. 2B). By 
the end of a period of at least five passages, the two 
types of cells exhibited the homogeneous morpholo-
gy. At passage 5, the T1 cell line was purified, and 
mouse cell contamination was not detected using an 
anti-human nucleus antibody (Fig. 2C). A short tan-
dem repeat (STR) analysis, which was conducted by 
the Center of Forensic Sciences Beijing Genomics In-
stitute, was employed to monitor the genomic insta-
bility. STR loci consisted of short, repetitive sequence 
elements with 3 to 7 base pairs in  length. The STR 
markers were employed to detect the variability be-
tween the T1 cells and the hsNSCs. The boxed num-
bers  and  corresponding  peaks  between  the  hsNSCs 
and  the  T1  cells  were  different  (Fig.  2D-2F).  These 
alterations  indicated  that  the  T1  cell  line  exhibited 
genomic instability. Based on these data, the T1 cells 
were confirmed as a pure population of tumor cells 
that  originated  from  the  transformation  of  the 
hsNSCs. 
Immunophenotype analysis of parental neural 
stem cells (hsNSCs) and T1 cells by FACS 
Variable  levels  of  antigen  expression  were  ob-
served for the markers of cell’s capacity of division 
and  proliferation  in  the  study,  as  shown  in  Fig  3. 
PCNA  analysis  results  showed  that  T1  cells  had  a 
proliferative  capacity  that  was  stronger  than  the 
hsNSCs (Fig. 3A, B). Upon staining hsNSCs and T1 
cells simultaneously for CD117, CXCR4, we observed 
a  marked  upregulated  expression  in  T1  cells  (Fig. 
3C-F). In contrast, the expression of CD133 in hsNSCs 
and T1 cells was relatively uniform (Fig. 3G, 3H). To-
gether,  these  data  had  revealed  certain  important 
molecular and biological changes that could contrib-
ute to the tumorigenicity of T1 cell line. 
 
 
 
Fig. 1. Subcutaneous tumorigenesis in immunodeficient nude mice injected with long-term cultured hsNSCs (A, B). Tumors 
were observed in 2 out of 15 mice. Karyotype analyses were performed on passage 17 hsNSCs and T1 cells. The karyotype 
of hsNSCs was analyzed using the G-banding staining method. Normal human diploid karyotype was maintained throughout 
the in vitro culture period (C), whereas a large number of different numerical and structural chromosomal aberrations were 
detected in the T1 cells (D). H&E staining (E, F) showed that the neoplasias proliferated actively. Large areas of necrosis 
surrounded by highly packed tumor cells were observed within the tumors. Many mitotic figures were demonstrated. Im-
munohistochemistry results indicated that the isolated tumors were immunoreactive for neuroendocrine tumor markers CgA 
(G) and NSE (H), but were negative for CD99 (I), cytokeratin AE1/AE3 (J), synaptophysin (K) and GFAP (L). Black arrowheads 
show the mitosis of spindles or equatorial planes. Scale bar: E, 100 µm; F-L, 20 µm. Int. J. Biol. Sci. 2011, 7 
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Fig. 2. Identification and characterization of T1 cell line. Cell cycle and PCNA analysis indicated that the percentages were 
42.60% (A) for the S phase cells and 91.46% positive for PCNA (B) respectively in T1 cells. Immunofluorescence assay showed 
the image of nuclear staining, using an anti-human nucleus antibody (C). Nuclei were stained with DAPI (Scale bar: 100 m). 
DNA fingerprinting with the STR markers of the donor hsNSCs (passage 22, 28 respectively) and the T1 cells was examined 
and compared (D-F). The boxed numbers and corresponding peaks of the hsNSCs at passage 22 and 28 were completely 
identical, but were significantly different from those of the T1 cells.  
 
 
The neoplasias of long-term cultured T1 cells 
were restricted in the brain after transplantation 
into nude mice 
To  determine  the  in  vivo  tumorigenicity,  the 
xenograft  tissues  were  obtained  through  serial  sub-
cutaneous  passage  in  immunodeficient  nude  mice 
according to the method described in the Material and 
Methods  section.  Serial  subcutaneous  transplanta-
tions  of  T1  xenograft  tissues  were  performed  and 
measured  in  the  immunodeficient  nude  mice  (Fig. 
4A).  However,  we  were  surprised  that  during 
long-term in vitro culture, the T1 cells did not result in 
xenografts  subcutaneously.  Since  the  T1  cells  were 
transformed from neural stem cells, we injected the T1 
cells  that  were  cultured  in vitro  for  long  periods  of 
time into the brains of immunodeficient nude mice to 
test intracranial neoplasias. After one to two months, 
all five nude mice were fleshless and unresponsive. 
Histologically, the intracranial neoplasias were poorly 
differentiated tumors (Fig. 4B, 4C). These tumor cells 
invaded  the  surrounding  normal  nervous  tissues. 
H&E staining analysis revealed that these tumor cells 
had large, oval nuclei with some prominent nucleoli. 
Spindles or equatorial planes were also observed in 
some  tumor  cells,  implying  that  these  tumor  cells 
could proliferate quickly (Fig. 4B, 4C). Immunofluo-
rescence analysis indicated that the GFAP of the in-
tracranial neoplasias was changed from the negative 
to  positive  in  the  subcutaneous  xenografts  (Fig. 
4D-4F). H&E staining (Fig 4G, 4H) show the sections 
of nude mice brain with hsNSC transplantation. Black 
arrow indicates the neural scar after neural stem cells 
transplantation.  White  arrow  indicates  the  needle 
trajectory of neural stem cells transplantation (Scale 
bar: 1000μm). These data indicated that the T1 cells 
could  grow  into  tumors  in  the  brain,  and  the  neo-
plasias  were  similar  to  tumors  derived  from  the 
nervous system. 
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Fig. 3. Immunophenotype analysis of parental neural stem 
cells (hsNSCs) and T1 cells by FACS. PCNA analysis indicated 
that T1 cells had a stronger proliferative capacity than the 
parental neural stem cells (hsNSCs) (A-B). CXCR4 and CD117 
were marked upregulated in T1 cells in comparison with 
hsNSCs (C-F). However, the expression of CD133 and EGFR 
in hsNSCs and T1 cells demonstrated no significant differ-
ence (G-J).  
T1 cell line shows stem cell-like features and 
initiates intracranial tumor formation 
From  the  results  demonstrated  above,  the  T1 
cells exhibited strong proliferation activities. We fur-
ther found that these T1 cells showed stem cell-like 
features and expressed neural stem cell markers nes-
tin and CD133 (Fig. 5A). The environmental factors 
involved in the T1 cell line were also determined. Both 
CXCR4 (Fig. 5B) and EGFR (Fig. 5C) were detected 
during brain tumorigenesis. EGFRvIII was also iden-
tified in the T1 cells (Fig. 5D). CXCR4 in the T1 cells 
showed polarity (Fig. 5B), indicating that the T1 cells 
possessed the potential for migration under the action 
of chemokines. The sections of tumor tissues derived 
from  T1  cell  intracranial  transplantation  also  ex-
pressed  CXCR4,  EGFR  and  EGFRvIII  (Fig.  5E-5G). 
The glial cell marker GFAP was still positive (Fig. 5G). 
It is known that the mutant of the  EGFR gene EG-
FRvIII was involved in the majority of cases of glio-
blastoma  multiforme  (GBMs)  with  EGFR  amplifica-
tion [13]. Thus, we separated CD133(+) and CD133(-) 
cells  from  the  intracranial  T1  tumors  using  the 
CD133-specific  antibody  (Fig.5I),  and  then  deter-
mined the status of the EGFRvIII mutant. The RT-PCR 
assay was used to analyze the EGFRvIII mutation. We 
found  that  the  CD133(-)  T1  cells  showed  both  the 
EGFR (1044-bp) and EGFRvIII (243-bp) bands, while 
the CD133(+) T1 cells only showed the EGFRvIII band 
(Fig. 5H). The sequencing result of the EGFRvIII gene 
was shown in Fig.5J. Together, these data suggest that 
EGFRvIII played an important role in the brain tumor 
formation.  
DISCUSSION 
Adult human neural stem cells have been con-
sidered as a resource for cell therapy and tissue engi-
neering  [7,  13-14].  Due  to  their  capabilities  of 
self-renewal  and  differentiation  towards  the  neural 
cells, NSCs provide an attractive tool for transplanta-
tion-based  therapy  of  neurodegenerative  diseases 
[15-16]. In vitro NSC expansion makes it possible to 
obtain  sufficient  amounts  of  NSCs  for  clinical  use. 
However,  a  potential  risk  of  NSC  treatment  might 
arise in that NSCs can paradoxically promote tumor-
igenesis. It has been reported that after prolonged in 
vitro culture, human adipose derived MSCs, murine 
bone marrow derived stem cells, and NSCs can be-
come  tumorigenic  [3-6].  Long-term  in vitro  cultured 
NSCs may be particularly prone to genomic instabil-
ity. Therefore, it is critical to evaluate the risk of hu-
man  NSCs  transformation  after  long-term  in  vitro 
culture.  
In this study, following long-term hsNSC culture 
in vitro,  we  observed  spontaneous  malignant  trans-
formation following the subcutaneous transplantation 
of hsNSCs into immunodeficient nude mice. We es-
tablished a T1 cell line derived from the tumor grow-
ing out of the transformed hsNSCs at passage 17 fol-
lowing  subcutaneous  xenograft.  The  T1  cell  line Int. J. Biol. Sci. 2011, 7 
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showed stem cell-like features and expressed neural 
stem  cell  markers  nestin  and  CD133.  STR  analysis 
indicated critical genomic instability that might have 
led to the transformation of hsNSCs. Thus, the T1 cells 
were  involved  in  the  abnormal  karyotypes  and  ge-
nomic instability. Genetic alteration such as amplifi-
cations, mutations or deletions of genes might lead to 
a decoupling of the biological mechanisms involved 
in the regulation of normal cell growth and differen-
tiation [11,17-20]. A difference between serial subcu-
taneous and intracranial tumorigenesis was observed 
in this study. During long-term in vitro culture, the T1 
cells did not result in subcutaneous xenograft, but led 
to  obvious  intracranial  tumor  formation,  indicating 
that these cells adjusted themselves to the intracranial 
microenvironment. The neoplasias were restricted in 
the brain and they opted for selecting their favorite 
microenvironment.  Although  it  remains  largely  un-
known why the transformations of the hsNSCs and T1 
cells  occurred  in  response  to  distinct  microenviron-
ments, it has been widely accepted that the host mi-
croenvironment plays a crucial role in cancer initia-
tion and progression [21-23]. 
 
 
 
 
Fig. 4. Intracranial tumorigenicity of T1 cells in immunodeficient nude mice. Serial 4 subcutaneous passages of T1 tumor 
formation were shown (A). The size of the tumors could be seen using the scale of the ruler, each grid represents 1 mm. H&E 
staining of the brain tissues of immunodeficient nude mice after T1 cell intracranial transplantation: space-occupying 
lesions in the lateral ventricle, as well as many atypical and prominent nuclei, were shown in high magnification view fields 
(Scale bar: B 100m; C 50m). Black arrowheads showed the mitosis of the equatorial plane (B, C). The brain tissue sections 
of immunodeficient nude mice after T1 cell transplantation were used for immunofluorescence analysis. The anti-human 
nucleus antibody staining was positive for the tumor cells (D). Some tumor cells were immunoreactive for glial cell’s marker 
GFAP (E, F). Nuclei were detected using the DAPI staining showed in merged image (F) (Scale bar: 40m). H&E staining (G-H) 
show the sections of nude mice brain with hsNSC transplantation. Black arrow indicates the neural scar after neural stem 
cells transplantation. White arrow indicates the needle trajectory of neural stem cells transplantation (Scale bar: 1000μm). Int. J. Biol. Sci. 2011, 7 
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Fig. 5. Immunofluorescence assays showed that the T1 cells expressed neural stem cell markers nestin (red & red arrow-
heads) and CD133 (green & green arrowheads A). Scale bar, 20 m. CXCR4 (B), EGFR (C) and EGFRvIII (D) were expressed in 
the T1 cells. Scale bar, 50 m). Immunoflurescence analyses of tumor tissue sections (Scale bar: 20 m) derived from T1 cell 
intracranial transplantation are shown (E-G). EGFR (green) and GFAP (red) were both expressed by transplanted T1 cells 
(G). Nuclei were detected using the DAPI staining method (blue). The RT-PCR results showed that the products of EGFR and 
EGFRvIII were 1044-bp and 243-bp (H), respectively. Lane 1 was for the neurospheres samples, showing EGFR 1044bp band; 
Lane 2 was for the CD133(-) T1 cells, showing two bands including EGFR (1044bp) and EGFRvIII (243bp); Lane 3 was for the 
CD133(+) T1 cells, and showed the 243-bp EGFRvIII band only. The CD133(+) and CD133(-) cells from intracranial T1 
cell-induced tumor were separated using the CD133-specific antibody (I). Sequencing result confirmed the expression of the 
EGFRvIII gene (J). 
 
We detected strongly CD117 (KIT) expression in 
T1  cells  using  FACS.  A  growing  body  of  evidence 
suggests that the KIT receptor involved in SCF sig-
naling is highly activated, which enhances endothelial 
cell proliferation in the brain microvasculature both in 
vivo and in vitro [24-25]. Both CXCR4 and EGFR are 
critical receptors involved in biological pathways be-
cause of their roles in inflammation, development and 
tumorigenesis [26-28]. CXCR4 is an important mole-
cule involved in the spread and progression of a va-
riety of tumors [26,29-31]. Recent investigations have 
revealed  that  chemokines  are  often  up-regulated 
within  areas  of  brain  pathology  and  may  provide 
crucial signaling cues for stem cell migration [23,32]. 
Overexpression or activation of the epidermal growth 
factor receptor (EGFR), a receptor tyrosine kinase as-
sociated with cell proliferation and survival, is often 
found  in  tumors[33].  Crosstalk  between  EGFR  and 
CXCR4 has recently been found to play an important 
role in the development of tumors [34]. Our findings 
revealed  that  T1  cells  overexpress  EGFR,  and  the 
CD133 positive T1 cells show a truncation mutation in 
the exons 2-7 of the EGFR gene (EGFRvIII). EGFRvIII 
is caused by deletion of exons 2 to 7, resulting in a 
protein  that  lacks  a  ligand-binding  domain  and  is 
constitutively activated. EGFRvIII is further resistant 
to down-regulation due to a low rate of receptor en-
docytosis  [35-37].  Mutant  forms  of  the  EGFR  gene 
have been reported to participate in tumorigenesis for 
patients with malignant gliomas [38-40].  Int. J. Biol. Sci. 2011, 7 
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In conclusion, our results strongly suggest that 
the  risk  of  malignant  spontaneous  transformation 
might result from the genomic instability caused by 
the continuous expansion of neural stem cells in vitro. 
The microenvironments play a crucial role in the in-
tracranial tumor initiation and progression. Since the 
mutant  EGFR  gene  EGFRvIII  was  involved  in  the 
majority  of  cases  of  glioblastoma  multiforme  with 
EGFR amplification  [13], the intracranial tumor for-
mation observed in our study might be related to the 
EGFRvIII gene during the process of tumorigenesis.  
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Additional Figures 
 
Fig. S1: Nude mice mortality curves. Mice receiving EGFR positive cells lived much longer than the mice receiving 
EGFRvIII positive cells as shown in Kaplan-Meier survival curves. These cells (10
4/mouse) were transplanted into the 
brains of nude mice, respectively. Mice mortality curves were analyzed using the Kaplan-Meier method, with groups 
compared by respective number of days taken to reach 50% mortality. 
 
Fig. S2: Immnohistochemistry assay showing different expressed EGFRVIII in hsNSCs (left) and in T1 cells (right).  